EX
Exelixis
EXEL·NASDAQAlameda CAFounded 1994850 employees
Mid CapbiotechPublicOncology
Platform: Cabo & ADCs
Market Cap
$8B
All Drugs
4
Clinical Trials
9
Failed / Terminated
3
FDA Approved
0
Stock Price & Catalysts (EXEL)
Loading EXEL stock data...
Drug Pipeline (4 programs)
| Drug Name | Code | Phase | Trials | Modality | Target | MOA | Indications |
|---|---|---|---|---|---|---|---|
| Bemasotorasib | EXE-1077 | Phase 2 | 2 | CD38 | MCLACC | ||
| Rimasertib | EXE-9923 | Phase 3 | 2 | B7-H3 | RettPancreatic Ca | ||
| Talasotorasib | EXE-2911 | Preclinical | 2 | APOC3 | SCDTTR Amyloidosis | ||
| Nidaratamab | EXE-272 | Phase 3 | 3 | FLT3 | AsthmaMM |
SEC Filings & Financial Documents
Insider Trading Activity
Fetching insider trading data from SEC EDGAR...
Catalyst Events (9)